Articles
03.12.2018
NICE META tool assisting patient access

NICE has recently developed the META tool, to support MedTech manufacturers in the identification of...

Read more
Articles
24.10.2018
Patient access to high-cost orphan drugs

Orphan drugs have important societal value as they improve patient quality of life and address unmet...

Read more
Articles
11.09.2018
NICE providing access to CAR-T therapy

Earlier this year, the UK government announced support for three new specialist centres capable of c...

Read more
Articles
29.08.2018
Brexit pharmaceutical market access and the UK

With eight months left before the UK leaves the EU in March 2019, it was hoped that a clear strategy...

Read more
Articles
24.08.2018
Treatment for rare conditions

Faster access to new treatments for very rare conditions announced following a revised decision maki...

Read more
Articles
17.08.2018
Biosimilars Price Controls

The government has launched a consultation that outlines the proposed changes to its price controls ...

Read more
Articles
25.07.2018
EU-wide HTA clinical assessment

The European Commission (EC) has recently set out its draft proposal for adopting an EU-wide health...

Read more
Articles
07.06.2018
Addressing antimicrobial resistance (AMR)

At the current rate, annual deaths due to AMR is expected to reach 10 million by 2050 globally, with...

Read more
Articles
25.05.2018
Remap Consulting Privacy Policy

As per our privacy policy we are committed to protecting the rights and freedoms of data subjects by...

Read more
Articles
27.04.2018
Indication based pricing

In the current climate of tighter budgetary controls and greater price scrutiny, a uniform pricing s...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.